Skip Navigation

European Journal of Heart Failure 2002 4(3):283-287; doi:10.1016/S1388-9842(01)00213-6
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rogers, A.
Right arrow Articles by Gibbs, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rogers, A.
Right arrow Articles by Gibbs, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2002 European Society of Cardiology

A qualitative study of chronic heart failure patients’ understanding of their symptoms and drug therapy

Angie Rogersa,*, Julia M. Addington-Halla, Anne S.M. McCoyb, Polly M. Edmondsa, Alison J. Aberyb, Andrew J.S. Coatsb, J. Simon and R. Gibbsb

a Department of Palliative Care and Policy Kings College London, London, UK
b Department of Clinical Cardiology, National Heart and Lung Institute at Imperial College of Science Technology and Medicine, London, UK

* Corresponding author. Tel.: +44-020-7848-5579; fax: +020-7848-5565. E-mail address: angela.rogers{at}kcl.ac.uk


   Abstract

Objectives: To explore patients’ understanding of their symptoms and the treatment of their heart failure.

Design: Qualitative analysis of in-depth interviews, using a constant comparative approach.

Subjects: 27 patients identified by Cardiology and Care of the Elderly physicians as having (a) symptomatic heart failure (New York Heart Association functional classes II, III and IV) and (b) a hospital admission for heart failure in the previous 20 months.

Results: Patients were aged between 38–94 years (mean 69), 20 were in NYHA functional class III or IV. All had at least one concurrent illness. Analysis of the data identified four key areas: patients had little understanding of the purpose of their medications, were concerned about both the quantity and combination of drugs they were prescribed, had difficulties in differentiating between the side effects of drugs and symptoms of heart failure, and had little knowledge to help them interpret and/or treat changing symptoms.

Conclusion: Providing patients with relevant information about their medications may help to reduce anxiety about the drugs they are taking. Acknowledging the symptoms associated with heart failure and the likely side effects of treatments might improve patients’ ability to interpret, treat or relieve symptoms.

Key Words: Heart failure • Symptoms • Drug therapy • Patient education

Received February 20, 2001; Revised June 29, 2001; Accepted September 7, 2001


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur J Heart FailHome page
T. Jaarsma, J. M. Beattie, M. Ryder, F. H. Rutten, T. McDonagh, P. Mohacsi, S. A. Murray, T. Grodzicki, I. Bergh, M. Metra, et al.
Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology
Eur J Heart Fail, May 1, 2009; 11(5): 433 - 443.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. Ekman and K. Swedberg
Patients' Persistence of Evidence-Based Treatment of Chronic Heart Failure: A Treatment Paradox
Circulation, August 14, 2007; 116(7): 693 - 695.
[Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
M. J Johnson
Management of end stage cardiac failure
Postgrad. Med. J., June 1, 2007; 83(980): 395 - 401.
[Abstract] [Full Text] [PDF]


Home page
Fam PractHome page
K. Field, S. Ziebland, A. McPherson, and R. Lehman
'Can I come off the tablets now?' A qualitative analysis of heart failure patients' understanding of their medication
Fam. Pract., December 1, 2006; 23(6): 624 - 630.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
A. Stromberg
The crucial role of patient education in heart failure
Eur J Heart Fail, March 16, 2005; 7(3): 363 - 369.
[Abstract] [Full Text] [PDF]


Home page
Chronic IllnessHome page
F. Lloyd-Williams, S. Beaton, P. Goldstein, F. Mair, C. May, and S. Capewell
Patients' and nurses' views of nurse-led heart failure clinics in general practice: a qualitative study
Chronic Illness, March 1, 2005; 1(1): 39 - 47.
[Abstract] [PDF]


Home page
Eur J Heart FailHome page
K. J. Boyd, S. A. Murray, M. Kendall, A. Worth, T. F. Benton, and H. Clausen
Living with advanced heart failure: a prospective, community based study of patients and their carers
Eur J Heart Fail, August 1, 2004; 6(5): 585 - 591.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
M. Martinez-Selles, J. A. G. Robles, R. Munoz, J. A. Serrano, E. Frades, M. D. Munoa, and J. Almendral
Pharmacological treatment in patients with heart failure: patients knowledge and occurrence of polypharmacy, alternative medicine and immunizations
Eur J Heart Fail, March 1, 2004; 6(2): 219 - 226.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
K. Muller, G. Gamba, F. Jaquet, and B. Hess
Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV--efficacy and quality of life
Eur J Heart Fail, December 1, 2003; 5(6): 793 - 801.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.